A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients With Known or Suspected Focal Liver Lesions and Severe Renal Impairment
Conditions
Kidney
Phase III
Volunteers
Health Professionals
What is the purpose of this trial?
The overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in patients with known or suspected focal liver lesions and severe renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI.
- Ages18 years and older
- GenderBoth
- Trial withAscelia Pharma AB
- Start Date01/30/2020
- End Date11/29/2020
For more information about this study, contact:
Kristin DeFrancesco
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
- Last Updated05/12/2020
- Study HIC#2000026178